Clazakizumab (redirect from BMS-945429)
Clazakizumab (formerly ALD518 and BMS-945429), an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6...
2 KB (153 words) - 07:01, 2 December 2023
are in clinical trials: olokizumab (CDP6038) elsilimomab, clazakizumab (BMS-945429, ALD518), sirukumab (CNTO 136), levilimab (BCD-089), and CPSI-2364 an...
12 KB (1,289 words) - 19:20, 4 December 2023